Australian Biotech Hopes Nasal Spray Can Alter Course Of COVID-19 Spread
COPD Among Other Potential Areas
Executive Summary
ENA Respiratory expects its "preventive" nasal spray, which primes innate immunity against respiratory viruses including SARS-CoV-2, to play a meaningful role in protecting at-risk populations and lowering community transmission of COVID-19. It plans to explore the potential of the broad-spectrum antiviral immunomodulator in other areas, including COPD, and wider partnering opportunities.